TCT 30: PREMIUM Trial – Double-blind Study of Percutaneous Closure of Patent Foramen Ovale With the AMPLATZER PFO Occluder as a Treatment for Migraine With or Without Aura

Presenter: Jonathan M. Tobis

REGISTER for free or LOG IN to view this content

TCT 30: PREMIUM Trial – Double-blind Study of Percutaneous Closure of Patent Foramen Ovale With the AMPLATZER PFO Occluder as a Treatment for Migraine With or Without Aura

We Recommend